Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KCultivator Q&A: John Coler champions making a quick impact, packs of dolphins
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. Today Startland takes a closer look at startup ecosystem champion John Coler. Check out our features on Made in KC’s Tyler Enders, Hispanic business builder Pedro Zamora, ‘fashionpreneur’ Jordan Williams, Plexpod founder Gerald Smith, innovation coach Diana…
Backed by $4M round, Hilary’s Eat Well expanding organic food line, hiring 10-15 workers
Hilary’s Eat Well is growing its plant-based food line, company leaders said. The move to diversify the company’s offerings — as well as to more efficiently produce larger quantities of its free-from (dairy- and gluten-free) products — comes as the Lawrence-based operation moves its storage to an off-site facility, freeing up manufacturing space, said Lydia…
City challenges startup leaders to swap social media for in-person dialogue on regulation
Editor’s note: Rick Usher is a member of the Kansas City Startup Foundation’s policy committee, and Sarah Shipley is a board member for KCSF, the parent organization of Startland News. This piece was independently produced. There’s a void of shared awareness between city government and the startup community, Rick Usher said. That’s why government officials and leaders…
8-year-old Raytown entrepreneur strings together jewelry business
Raelynn Heath’s bling is inspiring, her mother said. The 8-year-old entrepreneur has spent half her life developing a brand built on crafting original jewelry and repairing broken pieces, she said. “We take a little bit of the old and the new and the practical,” said Regina Lastiee-Heath. Young Raelynn markets her jewelry on Facebook and…